These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 8701511

  • 1. [Salmeterol improves the control of disease in patients with moderate asthma. A comparative study of inhaled salmeterol 50 mg and salbutamol depot tablets 8 mg, both administered twice daily].
    Ringbaek TJ, Søes-Petersen U, Christensen M, Iversen ET, Rasmussen FV.
    Ugeskr Laeger; 1996 Jul 01; 158(27):3940-3. PubMed ID: 8701511
    [Abstract] [Full Text] [Related]

  • 2. [Salmeterol improves control in asthmatic patients treated in general practice. A comparative study of salmeterol (Serevent) and salbutamol (Ventoline) in patients with mild to moderate asthma].
    Staehr P, Vestbo I.
    Ugeskr Laeger; 1995 Jan 02; 157(1):36-40. PubMed ID: 7839545
    [Abstract] [Full Text] [Related]

  • 3. Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthma.
    Martin RJ, Kraft M, Beaucher WN, Kiechel F, Sublett JL, LaVallee N, Shilstone J.
    Ann Allergy Asthma Immunol; 1999 Aug 02; 83(2):121-6. PubMed ID: 10480584
    [Abstract] [Full Text] [Related]

  • 4. [Therapy of nocturnal asthma: salmeterol versus nocturnal administration of retard theophylline--comparison of effectiveness and tolerance].
    Ukena D, Koper I, Braun H, Leutz M, Schlimmer P, Sybrecht GW.
    Pneumologie; 1997 Mar 02; 51(3):317-23. PubMed ID: 9173422
    [Abstract] [Full Text] [Related]

  • 5. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening A, Haahtela T, Holgate ST, Picado C, Leff JA.
    Respir Med; 2000 Jun 02; 94(6):612-21. PubMed ID: 10921768
    [Abstract] [Full Text] [Related]

  • 6. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group.
    Britton MG, Earnshaw JS, Palmer JB.
    Eur Respir J; 1992 Oct 02; 5(9):1062-7. PubMed ID: 1426215
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug 02; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

  • 8. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M, Viani-Initial Study Group.
    Eur J Med Res; 2002 Jan 29; 7(1):1-7. PubMed ID: 11827834
    [Abstract] [Full Text] [Related]

  • 9. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate.
    Lundbäck B, Rönmark E, Lindberg A, Jonsson AC, Larsson LG, Pétavy F, James M.
    Respir Med; 2006 Jan 29; 100(1):2-10. PubMed ID: 16243498
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness and tolerability of high-dose salmeterol in cystic fibrosis.
    Hordvik NL, Sammut PH, Judy CG, Colombo JL.
    Pediatr Pulmonol; 2002 Oct 29; 34(4):287-96. PubMed ID: 12205570
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of salmeterol/fluticasone propionate delivered via a hydrofluoroalkane metered dose inhaler in Chinese patients with moderate asthma poorly controlled with inhaled corticosteroids.
    You-Ning L, Humphries M, Du X, Wang L, Jiang J.
    Int J Clin Pract; 2005 Jul 29; 59(7):754-9. PubMed ID: 15963199
    [Abstract] [Full Text] [Related]

  • 12. Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.
    Taylor DR, Town GI, Herbison GP, Boothman-Burrell D, Flannery EM, Hancox B, Harré E, Laubscher K, Linscott V, Ramsay CM, Richards G.
    Thorax; 1998 Sep 29; 53(9):744-52. PubMed ID: 10319056
    [Abstract] [Full Text] [Related]

  • 13. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U, Viktrup L, Davidsen O, Viskum K.
    Ugeskr Laeger; 1992 Nov 16; 154(47):3325-8. PubMed ID: 1361083
    [Abstract] [Full Text] [Related]

  • 14. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
    Cass LM, Gunawardena KA, Macmahon MM, Bye A.
    Respir Med; 2000 Feb 16; 94(2):166-73. PubMed ID: 10714424
    [Abstract] [Full Text] [Related]

  • 15. A placebo-controlled, crossover comparison of salmeterol and salbutamol in patients with asthma.
    Leblanc P, Knight A, Kreisman H, Borkhoff CM, Johnston PR.
    Am J Respir Crit Care Med; 1996 Aug 16; 154(2 Pt 1):324-8. PubMed ID: 8756801
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Efficacy of salmeterol in patients with allergic bronchial asthma].
    Pacor ML, Biasi D, Cortina P, Maleknia T, Lunardi C.
    Clin Ter; 1994 Aug 16; 145(8):131-4. PubMed ID: 7955958
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. An open multi-centre study to assess the efficacy of inhaled salmeterol in bronchial asthma in Nigeria.
    Onadeko BO, Bamidele EO, Ekweani CN, Erabor GE.
    Afr J Med Med Sci; 1994 Sep 16; 23(3):301-5. PubMed ID: 7604758
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.